Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

Abstract Background The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface of RS and TCMs were yet to be defined. T...

Full description

Bibliographic Details
Main Authors: Zuanji Liang, Yunfeng Lai, Meng Li, Junnan Shi, Chi Ieong Lei, Hao Hu, Carolina Oi Lam Ung
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Chinese Medicine
Subjects:
Regulatory Science
China
Traditional medicine
TCM
Drug Regulatory Authority
National Medical Products Administration
Online Access:https://doi.org/10.1186/s13020-021-00433-2

Internet

https://doi.org/10.1186/s13020-021-00433-2

Similar Items